This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

ZIOPHARM Oncology Inc (ZIOP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 68.20M 73.31M 104.71M 60.39M
Receivables 145.00K 58.00K 79.00K 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 70.30M 80.28M 106.10M 60.82M
Property, Plant & Equipment, Gross 2.95M 3.92M 2.47M 1.31M
Accumulated Depreciation & Depletion 2.15M 1.92M 1.32M 1.06M
Property, Plant & Equipment, Net 801.00K 1.99M 1.14M 253.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 656.00K 1.13M 862.00K 451.00K
Total Non-Current Assets 1.46M 3.13M 2.00M 704.00K
Liabilities & Shareholder Equity
Total Assets 71.75M 83.40M 108.11M 61.52M
Accounts Payable 422.00K 1.51M 1.73M 1.03M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 212.00K 39.00K 263.00K 0.00
Total Current Liabilities 7.79M 18.86M 13.36M 3.61M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 851.00K 400.00K 0.00 0.00
Other Non-Current Liabilities 13.73M 15.70M 23.14M 27.36M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 14.58M 16.10M 23.14M 27.36M
Total Liabilities 22.37M 34.96M 36.50M 30.97M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 49.38M 48.44M 71.61M 30.55M
Common Par 100.00K 83.00K 69.00K 48.00K
Additional Paid In Capital 390.11M 332.09M 259.13M 154.32M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -340.83M -283.72M -187.59M -123.81M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 49.38M 48.44M 71.61M 30.55M
Total Equity 49.38M 48.44M 71.61M 30.55M
Total Liabilities & Stock Equity 71.75M 83.40M 108.11M 61.52M
Total Common Shares Outstanding 100.16M 83.24M 69.21M 48.47M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 85.94M 78.55M 66.00M 46.00M
Diluted Weighted Shares Outstanding 85.94M 78.55M 66.00M 46.00M
Number of Employees 43 83 66 32
Number of Part-Time Employees 0 0 0 1
ZIOP News

ZIOP ZIOPHARM Oncology Inc

Analysts Ratings for ZIOP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ZIOP ANALYST REPORT

Brokerage Partners

ZIOP Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs